145 related articles for article (PubMed ID: 37606040)
1. Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma.
Kobayashi S; Tokita S; Moniwa K; Kitahara K; Iuchi H; Matsuo K; Kakizaki H; Kanaseki T; Torigoe T
JCI Insight; 2023 Aug; 8(16):. PubMed ID: 37606040
[TBL] [Abstract][Full Text] [Related]
2. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
3. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.
Takahashi Y; Harashima N; Kajigaya S; Yokoyama H; Cherkasova E; McCoy JP; Hanada K; Mena O; Kurlander R; Tawab A; Srinivasan R; Lundqvist A; Malinzak E; Geller N; Lerman MI; Childs RW
J Clin Invest; 2008 Mar; 118(3):1099-109. PubMed ID: 18292810
[TBL] [Abstract][Full Text] [Related]
4. Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.
Cherkasova E; Scrivani C; Doh S; Weisman Q; Takahashi Y; Harashima N; Yokoyama H; Srinivasan R; Linehan WM; Lerman MI; Childs RW
Cancer Res; 2016 Apr; 76(8):2177-85. PubMed ID: 26862115
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.
Hirama T; Tokita S; Nakatsugawa M; Murata K; Nannya Y; Matsuo K; Inoko H; Hirohashi Y; Hashimoto S; Ogawa S; Takemasa I; Sato N; Hata F; Kanaseki T; Torigoe T
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34185709
[TBL] [Abstract][Full Text] [Related]
6. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.
Panda A; de Cubas AA; Stein M; Riedlinger G; Kra J; Mayer T; Smith CC; Vincent BG; Serody JS; Beckermann KE; Ganesan S; Bhanot G; Rathmell WK
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135306
[TBL] [Abstract][Full Text] [Related]
7. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
8. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
Schendel DJ; Gansbacher B; Oberneder R; Kriegmair M; Hofstetter A; Riethmüller G; Segurado OG
J Immunol; 1993 Oct; 151(8):4209-20. PubMed ID: 8409397
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
11. Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors.
Tsimafeyeu I; Volkova M; Olshanskaia A; Raskin G; Aschuba S; Khochenkova Y; Bondarenko A; Khochenkov D
Oncology; 2020; 98(4):252-258. PubMed ID: 32053815
[TBL] [Abstract][Full Text] [Related]
12. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Smith CC; Beckermann KE; Bortone DS; De Cubas AA; Bixby LM; Lee SJ; Panda A; Ganesan S; Bhanot G; Wallen EM; Milowsky MI; Kim WY; Rathmell WK; Swanstrom R; Parker JS; Serody JS; Selitsky SR; Vincent BG
J Clin Invest; 2018 Nov; 128(11):4804-4820. PubMed ID: 30137025
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
14. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
Wang QJ; Hanada K; Robbins PF; Li YF; Yang JC
Cancer Res; 2012 Dec; 72(23):6119-29. PubMed ID: 23071066
[TBL] [Abstract][Full Text] [Related]
15. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
16. Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.
Cai C; Xu YF; Wu ZJ; Dong Q; Li MY; Olson JC; Rabinowitz YM; Wang LH; Sun Y
World J Urol; 2016 Apr; 34(4):561-7. PubMed ID: 26253654
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.
Finke JH; Rayman P; Hart L; Alexander JP; Edinger MG; Tubbs RR; Klein E; Tuason L; Bukowski RM
J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):91-104. PubMed ID: 7907918
[TBL] [Abstract][Full Text] [Related]
18. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.
Cherkasova E; Malinzak E; Rao S; Takahashi Y; Senchenko VN; Kudryavtseva AV; Nickerson ML; Merino M; Hong JA; Schrump DS; Srinivasan R; Linehan WM; Tian X; Lerman MI; Childs RW
Oncogene; 2011 Nov; 30(47):4697-706. PubMed ID: 21602888
[TBL] [Abstract][Full Text] [Related]
20. Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Wickström SL; Lövgren T; Volkmar M; Reinhold B; Duke-Cohan JS; Hartmann L; Rebmann J; Mueller A; Melief J; Maas R; Ligtenberg M; Hansson J; Offringa R; Seliger B; Poschke I; Reinherz EL; Kiessling R
Front Immunol; 2019; 10():2766. PubMed ID: 31921104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
